single

Alembic Pharmaceuticals announced that the Company has receivedapproval from the US Food & Drug Administration (USFDA) for its Abbreviated NewDrug Application (ANDA) for Dorzolamide Hydrochloride Ophthalmic Solution USP,2%. The approved ANDA is therapeutically equivalent to the reference listed drugproduct (RLD) Trusopt Ophthalmic Solution, 2%, of Merck Sharp & Dohme Corp.Dorzolamide Hydrochloride Ophthalmic Solution is a carbonic anhydrase inhibitorindicated in the treatment of elevated intraocular pressure in patients with ocularhypertension or open-angle glaucoma.

Dorzolamide Hydrochloride Ophthalmic Solution USP, 2% has an estimated marketsize of US$ 35 million for twelve months ending December 2018 according to IQVIA

TAGS

0 thoughts on “Alembic Pharmaceuticals receives USFDA ANDA approval for Dorzolamide Hydrochloride Ophthalmic Solution”

Post Comment



  Stock Future Tips

Majority of the intraday traders are trading in stock future with decent capital as the profit is more. stock future tips are not as like cash calls which need to put number of shares to buy, all are said in lot basis which differed from each company.



Daily News

VIEW ALL
editor

View My Stats